FDA Import Refusal AEK-7854621-3/100002/1 — CAPLIN POINT LABORATORIES
The FDA refused shipment AEK-7854621-3/100002/1 from CAPLIN POINT LABORATORIES (Nicaragua) on Nov 17, 2025. The refused product falls under Drugs and Biologics — NEOMYCIN (AMINOGLYCOSIDES). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 17, 2025
- Country
- Nicaragua
- Product Category
- Drugs and Biologics
- Product Code
- 56DDJ40 NEOMYCIN (AMINOGLYCOSIDES)
- Charges
- 75